Invesaro

Stocks CLDX Earnings

Earnings

Celldex Therapeutics, Inc. (CLDX) earnings

Quarterly results of Celldex Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when CLDX files with the SEC.

Next earnings date

Celldex Therapeutics, Inc. is expected to report around February 24, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Celldex Therapeutics, Inc. reported revenue of - and a net loss of $75.6M.

Diluted earnings per share were -$0.96.

Filed with the SEC on November 5, 2026.

Revenue by quarter
Q4 24: $1.2M $1.2M Q4 24Q1 25: $695K $695K Q1 25Q2 25: $730K $730K Q2 25Q1 26: $15K $15K Q1 26Q2 26: $22K $22K Q2 26
Net income by quarter
Q4 24: -$47.1M -$47.1M Q4 24Q1 25: -$53.8M -$53.8M Q1 25Q2 25: -$56.6M -$56.6M Q2 25Q3 25: -$67M -$67M Q3 25Q4 25: -$81.3M -$81.3M Q4 25Q1 26: -$78.7M -$78.7M Q1 26Q2 26: -$73.5M -$73.5M Q2 26Q3 26: -$75.6M -$75.6M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026---$75.6M-$0.96
Q2 FY2026June 30, 2026$22K-97%-$73.5M-$0.94
Q1 FY2026March 31, 2026$15K-97.8%-$78.7M-$1.18
Q4 FY2025December 31, 2025---$81.3M-
Q3 FY2025September 30, 2025---$67M-$1.01
Q2 FY2025June 30, 2025$730K--$56.6M-$0.85
Q1 FY2025March 31, 2025$695K--$53.8M-$0.81
Q4 FY2024December 31, 2024$1.2M--$47.1M-

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Celldex Therapeutics, Inc.'s next earnings date?

Celldex Therapeutics, Inc. is expected to report around February 24, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Get an email when CLDX reports

Follow CLDX and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when CLDX files with the SEC.

Source: quarterly figures Celldex Therapeutics, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Celldex Therapeutics, Inc.